New York politician participates in clinical trial for COVID-19 vaccine


NEW YORK, NY – State Senator Brad Hoylman this week began participating in a clinical trial at the NYU Grossman School of Medicine for a COVID-19 vaccine.The Manhattan lawmaker, whose district stretches from the West Village to Central Park, is specifically participating in a Phase 3 clinical trial for a COVID-19 vaccine under the supervision of NYU Langone Health’s Vaccine Center.

“The development of a COVID-19 vaccine is the killing blow of our generation,” Hoylman said in a press release. “As a strong advocate for a science-based health policy to fight vaccine-preventable diseases, I am proud to have done my part by participating in a clinical trial for a COVID-19 vaccine at the Vaccine Center by NYU Langone Health.

“If this vaccine or other candidates are successful, we can stem the human suffering caused by COVID-19, protect our frontline workers and vulnerable New Yorkers from infection, and hopefully get our lives back soon.” daily, ”Hoylman added. the press release.

Hoylman is also urging other New Yorkers to know if they are eligible to participate in a COVID-19 vaccine trial.

If any of the current vaccine candidates receive regulatory approval, the manufacturer is expected to produce up to 100 million doses by the end of 2020, according to NYU Langone Health.

You can read more about participating in a vaccine trial at


Please enter your comment!
Please enter your name here